Status:
COMPLETED
An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.
Lead Sponsor:
Pfizer
Conditions:
Urinary Incontinence, Stress
Eligibility:
FEMALE
18-65 years
Phase:
PHASE2
Brief Summary
A study designed to assess the efficacy, toleration and safety of SS-RBX for the treatment of stress urinary incontinence.
Eligibility Criteria
Inclusion
- Clinically significant stress urinary incontinence
Exclusion
- History or evidence of any relevant confounding urological or neurological disease
Key Trial Info
Start Date :
November 1 2004
Trial Type :
INTERVENTIONAL
End Date :
August 1 2006
Estimated Enrollment :
402 Patients enrolled
Trial Details
Trial ID
NCT00138749
Start Date
November 1 2004
End Date
August 1 2006
Last Update
April 7 2011
Active Locations (95)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Anchorage, Alaska, United States, 99508
2
Pfizer Investigational Site
Sun City, Arizona, United States, 85351
3
Pfizer Investigational Site
Tucson, Arizona, United States, 85712-5803
4
Pfizer Investigational Site
Tucson, Arizona, United States, 85712